Anti-DNA Antibody Test



Test Description

The anti-DNA antibody test detects the presence of antibodies to native, or doublestranded
DNA. Presence of these antibodies indicates the person has some type of
autoimmune disease. The resultant antibody-antigen complexes which form play a
major part in the tissue injury involved in autoimmune diseases. These antibodies
are particularly prevalent in patients with systemic lupus erythematosus (SLE); thus,
this test is useful in the diagnosis of SLE and for monitoring the course of SLE.

Normal Values

∎Immunofluorescence method:                Negative at 1:10 dilution

ELISA method:                                            Negative<50 IU/mL

Borderline                                                     50–60 IU/mL

Positive                                                         >60 IU/mL


∎Enzyme immunoassay method:                      Negative<100 IU/mL A

Borderline                                                            100–300 IU/mL

Positive                                                                  >300 IU/mL


Possible Meanings of Abnormal Values

Increased                                                  
Lupus nephritis
Myasthenia gravis
Rheumatoid arthritis
Sclerosis
Sjögren’s syndrome
Systemic lupus erythematosus

Contributing Factors to Abnormal Values

• Hemolysis of the blood sample may alter test results.
• Drugs that may increase anti-DNA levels: hydralazine, procainamide.

Interventions/Implications

Pretest

• Explain to the patient the purpose of the test and the need for a blood sample to be drawn.
• Overnight fasting is preferred before the test.

   Procedure
• A 7-mL blood sample is drawn in a red-top collection tube.
• Gloves are worn throughout the procedure.

 Post test
• Apply pressure at venipuncture site. Apply dressing, periodically assessing for continued
  bleeding.
• Label the specimen and transport it to the laboratory.
• Report abnormal findings to the primary care provider

Clinical alert                          

• Risk of infection at venipuncture site due to immunocompromised state. Teach
  patient to notify health-care provider if drainage, redness, warmth, edema, or
  pain at the site or fever occur.

.

تعليقات

المشاركات الشائعة من هذه المدونة

Anti-Parietal Cell Antibody

انواع تحاليل السكر